Accepting new patients

Dr. Ho Myong, MD

Oncology ·  Male · Age 54

Dr. Myong

Cancer Care Institute

2000 Ogden Ave Aurora, IL 60504

Make an Appointment

Show Phone Number


Dr. Ho Myong, MD is an oncology specialist in Aurora, IL and has been practicing for 28 years. He graduated from University Of Illinois College Of Medicine Chicago in 1991 and specializes in oncology, medical oncology, and more.


Insurance Check

Search for your insurance provider

Dr. Myong accepts

Accepted insurance can change. Please double-check when making an appointment.

(630) 978-6250

Dr. Myong accepts the following insurance:

Aetna
Aetna HMO
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
Coventry Health Care
Coventry Health America PPO
Humana
Choice Care PPO
Preferred PPO
MultiPlan
MultiPlan PPO
PHCS Network PPO
Priority Health
Priority PPO

Background Check

No malpractice claims found for Illinois
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Myong's experience treating your condition or procedure

Dr. Myong's Top Procedures and Conditions

Treatment Frequency
Blood Disorders
very high
very high

Treatment Frequency

Dr. Myong treats Blood Disorders more than 93% of his peers

Dr. Myong treats this condition more than 93% of his peers

Cancer
very high
very high

Treatment Frequency

Dr. Myong treats Cancer more than 91% of his peers

Dr. Myong treats this condition more than 91% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Myelodysplastic Syndromes
high
high

Treatment Frequency

Dr. Myong treats Myelodysplastic Syndromes more than 86% of his peers

Dr. Myong treats this condition more than 86% of his peers

Rating Includes other areas of care:

  • Myelodysplastic Syndrome Associated With Isolated Del(5q) Chromosome Abnormality

Dr. Myong's conditions and procedures:

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • All Lymphoma
  • Anemia
  • Antiphospholipid Syndrome (APS)
  • Autoimmune Diseases
  • Bleeding Disorders
  • Blood Disorders
  • Blood Disorders in Pregnancy
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Cancer
  • Central Nervous System Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Defects in Pregnancy and Postpartum
  • Coagulation Disorders (incl. Hemophilia)
  • Cryoglobulinemia
  • Deep Vein Thrombosis (DVT)
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Leukocytosis
  • Lymphoma, Large-Cell
  • Lymphosarcoma
  • Marginal Zone Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Pancytopenia
  • Peripheral T-Cell Lymphoma
  • Polycythemia Rubra Vera
  • Pregnancy-Related Disorders
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Purpura
  • Reticulosarcoma
  • Sickle Cell Disease
  • Thalassemia
  • Thrombocytosis
  • Thrombosis
  • Vascular Disease
  • Venous Embolism and Thrombosis
  • von Willebrand Disease

About Me

Biography

Dr. Ho Myong, MD is an oncology specialist in Aurora, IL and has been practicing for 28 years. He graduated from University Of Illinois College Of Medicine Chicago in 1991 and specializes in oncology, medical oncology, and more.

Specialties

  • Oncology
  • Hematology
  • Medical Oncology

Board Certifications

  • Hematology
  • Internal Medicine
  • Medical Oncology

Education

1991
University Of Illinois College Of Medicine Chicago
Medical School
1991

Awards

Dr. Myong's Reviews

Likelihood to recommend Dr. Myong

3.7

Based on 3 reviews

5 Stars
66.66666666666667%
(2)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
33.333333333333336%
(1)

Leave a review

How likely are you to recommend
Dr. Myong?
(Select your rating)
Average Reported Wait Time
  • Under 10 minutes
Dr. Myong's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Ho Myong, MD
Reply
I, personally, have had a really good experience with Dr. Myong. He became my liason oncologist when I changed locations for chemotherapy. I found him to be kind, knowledgeable and understanding. He also provided some levity to my situation which I am very grateful for. I have never had to wait for him and he's answered every question I have had with satisfactory answers. His staff is wonderful and I am very happy.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Ho Myong, MD?
Reply
Dr. Myong was recommended by my PCP (who usually provides very good recommendations, so I trusted his judgement) after a sudden, unexplained DVT last summer. Dr. Myong was not the doctor to go to. He completely ignored my family history and medical history, deciding it was solely due to my "sedentary lifestyle" as I work a desI job. He refused to run an tests. Later, in an unrelated hospitalization, I had a PVT. They ran some basic blood panels and found a hereditary gene mutation.
Was this helpful?
thumbs up icon option
thumbs down icon option1
×Post a ResponseAre you Dr. Ho Myong, MD?

Leave a review

How was your experience with Dr. Myong?